Novel HTS strategy identifies TRAIL-sensitizing compounds acting specifically through the caspase-8 apoptotic axis.
about
Molecular targets for selective killing of TRAIL-resistant leukemic cells.Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPs.mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells.Smad7 protein induces interferon regulatory factor 1-dependent transcriptional activation of caspase 8 to restore tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosisReal-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors.Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development.Novel TRAIL sensitizer Taraxacum officinale F.H. Wigg enhances TRAIL-induced apoptosis in Huh7 cells.Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.Hypoxia Affects Neprilysin Expression Through Caspase Activation and an APP Intracellular Domain-dependent Mechanism.Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma MultiformeImplementation and Challenges of Direct Acoustic Dosing into Cell-Based Assays.Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.
P2860
Q33891400-7652D1F2-164A-49E9-BCC7-F2685B53C5EEQ35032216-676F62D4-1CF2-48B8-A098-6C6730BBAA24Q35273390-D4BE7950-19FC-440A-901A-CF87D1928335Q36579619-E53047D9-7B86-4166-9683-275D6A15CA23Q36913828-436AD6BC-949A-4A8C-9382-4F637222DF64Q37295309-8E7BB4E6-BC54-445B-997C-7602796DCE1DQ38913421-9EB1323D-EEEE-49F5-AACD-91C604C6F8ECQ39098785-D5768D79-41FD-4CEC-A031-BA30786F2691Q40263247-0EFA39E7-5B23-4480-A12D-84D6CE8F4D79Q42577813-DD858D2B-8160-45A4-8F07-3F994D131DC8Q48012162-767ABCED-9A83-4DFF-A331-507080A64B2BQ48531636-87386418-F337-4DA4-A5C6-A330CAED56DD
P2860
Novel HTS strategy identifies TRAIL-sensitizing compounds acting specifically through the caspase-8 apoptotic axis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Novel HTS strategy identifies ...... the caspase-8 apoptotic axis.
@ast
Novel HTS strategy identifies ...... the caspase-8 apoptotic axis.
@en
type
label
Novel HTS strategy identifies ...... the caspase-8 apoptotic axis.
@ast
Novel HTS strategy identifies ...... the caspase-8 apoptotic axis.
@en
prefLabel
Novel HTS strategy identifies ...... the caspase-8 apoptotic axis.
@ast
Novel HTS strategy identifies ...... the caspase-8 apoptotic axis.
@en
P2093
P2860
P1433
P1476
Novel HTS strategy identifies ...... the caspase-8 apoptotic axis.
@en
P2093
Amy L Howes
Darren Finlay
Kristiina Vuori
Lisa K Landberg
Robyn D Richardson
P2860
P304
P356
10.1371/JOURNAL.PONE.0013375
P407
P577
2010-10-12T00:00:00Z